Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Other Accumulated Expenses (2021 - 2022)

Historic Other Accumulated Expenses for Cullinan Therapeutics (CGEM) over the last 2 years, with Q4 2022 value amounting to $2.0 million.

  • Cullinan Therapeutics' Other Accumulated Expenses rose 10092.5% to $2.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $2.0 million, marking a year-over-year increase of 10092.5%. This contributed to the annual value of $2.0 million for FY2022, which is 10092.5% up from last year.
  • Cullinan Therapeutics' Other Accumulated Expenses amounted to $2.0 million in Q4 2022, which was up 10092.5% from $973000.0 recorded in Q4 2021.
  • In the past 5 years, Cullinan Therapeutics' Other Accumulated Expenses ranged from a high of $2.0 million in Q4 2022 and a low of $973000.0 during Q4 2021